![Kevin Connolly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Connolly
Keine laufenden Positionen mehr
Profil
Kevin Connolly worked as a Director-Anthrax Vaccines at PharmAthene, Inc. in 2011.
He completed his undergraduate degree at The Johns Hopkins University and his doctorate degree at Medical College of Virginia.
Ehemalige bekannte Positionen von Kevin Connolly
Unternehmen | Position | Ende |
---|---|---|
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Corporate Officer/Principal | - |
Ausbildung von Kevin Connolly
The Johns Hopkins University | Undergraduate Degree |
Medical College of Virginia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |